社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
彻夜笙歌
IP属地:未知
+关注
帖子 · 3
帖子 · 3
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
彻夜笙歌
彻夜笙歌
·
02-27
$MIRXES-B(02629)$
2月23日,Mirxes觅瑞发布自愿性公告,宣布其结直肠癌早筛前瞻性临床研究CADENCE CRC已完成全部入组。该研究是东盟地区首项、也是规模最大的血液肠癌筛查注册性研究,标志着觅瑞肠癌早筛临床验证进入关键阶段,为后续商业化落地奠定坚实基础,充分体现出公司深耕东盟与中国市场的战略布局取得显著成效。
看
304
回复
评论
点赞
1
编组 21备份 2
分享
举报
彻夜笙歌
彻夜笙歌
·
2025-11-20
$MIRXES-B(02629)$
觅瑞觅小卫®已经获得中国国家药品监督管理局(NMPA)第三类医疗器械注册证了,这意味着产品可以直接作为胃癌早期筛查的独立工具投入临床应用。期待!
看
752
回复
评论
点赞
1
编组 21备份 2
分享
举报
彻夜笙歌
彻夜笙歌
·
2025-06-24
现在港股市场怎么样?
看
507
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4213855129601350","uuid":"4213855129601350","gmtCreate":1750751942174,"gmtModify":1750751952626,"name":"彻夜笙歌","pinyin":"cysgcheyeshengge","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":537152470570080,"gmtCreate":1772161627904,"gmtModify":1772161748168,"author":{"id":"4213855129601350","authorId":"4213855129601350","name":"彻夜笙歌","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4213855129601350","idStr":"4213855129601350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 2月23日,Mirxes觅瑞发布自愿性公告,宣布其结直肠癌早筛前瞻性临床研究CADENCE CRC已完成全部入组。该研究是东盟地区首项、也是规模最大的血液肠癌筛查注册性研究,标志着觅瑞肠癌早筛临床验证进入关键阶段,为后续商业化落地奠定坚实基础,充分体现出公司深耕东盟与中国市场的战略布局取得显著成效。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 2月23日,Mirxes觅瑞发布自愿性公告,宣布其结直肠癌早筛前瞻性临床研究CADENCE CRC已完成全部入组。该研究是东盟地区首项、也是规模最大的血液肠癌筛查注册性研究,标志着觅瑞肠癌早筛临床验证进入关键阶段,为后续商业化落地奠定坚实基础,充分体现出公司深耕东盟与中国市场的战略布局取得显著成效。","text":"$MIRXES-B(02629)$ 2月23日,Mirxes觅瑞发布自愿性公告,宣布其结直肠癌早筛前瞻性临床研究CADENCE CRC已完成全部入组。该研究是东盟地区首项、也是规模最大的血液肠癌筛查注册性研究,标志着觅瑞肠癌早筛临床验证进入关键阶段,为后续商业化落地奠定坚实基础,充分体现出公司深耕东盟与中国市场的战略布局取得显著成效。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/537152470570080","isVote":1,"tweetType":1,"viewCount":304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":502171097158448,"gmtCreate":1763619336208,"gmtModify":1763621032799,"author":{"id":"4213855129601350","authorId":"4213855129601350","name":"彻夜笙歌","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4213855129601350","idStr":"4213855129601350"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 觅瑞觅小卫®已经获得中国国家药品监督管理局(NMPA)第三类医疗器械注册证了,这意味着产品可以直接作为胃癌早期筛查的独立工具投入临床应用。期待!","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 觅瑞觅小卫®已经获得中国国家药品监督管理局(NMPA)第三类医疗器械注册证了,这意味着产品可以直接作为胃癌早期筛查的独立工具投入临床应用。期待!","text":"$MIRXES-B(02629)$ 觅瑞觅小卫®已经获得中国国家药品监督管理局(NMPA)第三类医疗器械注册证了,这意味着产品可以直接作为胃癌早期筛查的独立工具投入临床应用。期待!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/502171097158448","isVote":1,"tweetType":1,"viewCount":752,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":449438571815504,"gmtCreate":1750752708558,"gmtModify":1750753415777,"author":{"id":"4213855129601350","authorId":"4213855129601350","name":"彻夜笙歌","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4213855129601350","idStr":"4213855129601350"},"themes":[],"title":"","htmlText":"现在港股市场怎么样?","listText":"现在港股市场怎么样?","text":"现在港股市场怎么样?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/449438571815504","isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}